Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
414.40    -2.40 (-0.58%)
Bid:
412.60
Ask:
413.40
Spread: 0.80 (0.194%)
Market Cap: £2.13b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Director/PDMR Shareholding

12 Jun 2018 17:19

RNS Number : 1786R
QinetiQ Group plc
12 June 2018
ย 

ย 

QinetiQ Group plc (the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

(a)

Name

Steve Wadey

2.

Reason for the notification

(a)

Position / status

Chief Executive Officer

(b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

QinetiQ Group plc

(b)

Legal Entity Identifier Code

213800S8OBDOZMCMUW34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

ย 

(a)

ย 

Description of the financial instrument

ย 

Identification code

ย 

ย 

ย 

QinetiQ Group plc ordinary shares of 1 pence

ย 

ย 

GB00B0WMWD03

(b)

Nature of the transaction

Conditional award of shares under the 2017 QinetiQ Group plc Deferred Share Plan, subject to a performance underpin over a three year period. The expected vesting date is 8 June 2021.

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

ยฃ2.06

220,785

ย 

(d)

ย 

Aggregated information

ย 

- Price

ย 

- Volume

ย 

- Total

ย 

ย 

N/A

ย 

ย 

(e)

Date of the transaction

2018-06-08

(f)

Place of the transaction

Outside of trading venue

ย 

ย 

QinetiQ Group plc (the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

(a)

Name

David Smith

2.

Reason for the notification

(a)

Position / status

Chief Financial Officer

(b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

QinetiQ Group plc

(b)

Legal Entity Identifier Code

213800S8OBDOZMCMUW34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

ย 

(a)

ย 

Description of the financial instrument

ย 

Identification code

ย 

ย 

ย 

QinetiQ Group plc ordinary shares of 1 pence

ย 

ย 

GB00B0WMWD03

(b)

Nature of the transaction

Conditional award of shares under the 2017 QinetiQ Group plc Deferred Share Plan, subject to a performance underpin over a three year period. The expected vesting date is 8 June 2021.

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

ยฃ2.06

167,975

ย 

(d)

ย 

Aggregated information

ย 

- Price

ย 

- Volume

ย 

- Total

ย 

ย 

N/A

ย 

ย 

(e)

Date of the transaction

2018-06-08

(f)

Place of the transaction

Outside of trading venue

ย 

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
ย 
END
ย 
ย 
DSHSFWFMEFASEFM
Date   Source Headline
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.